Disclosures for "Testosterone Therapy in a Transgender Male Patient as a cause of Acute Ischemic Stroke ")
-
Dr. Tan has nothing to disclose.
-
Mrs. Kim Sing has nothing to disclose.
-
Dr. Danziger has nothing to disclose.
-
Mr. AW has nothing to disclose.
-
Dr. Kim has nothing to disclose.
-
Dr. Avila has nothing to disclose.
-
Dr. Alambyan has stock in Teleflex. Dr. Alambyan has stock in Natera. Dr. Alambyan has stock in Labcorp. Dr. Alambyan has stock in Veracyte. Dr. Alambyan has stock in Vicarious Surgical. Dr. Alambyan has stock in Unity Biotechnology. Dr. Alambyan has stock in Scynexis. Dr. Alambyan has stock in Stryker. Dr. Alambyan has stock in Eli Lilly. Dr. Alambyan has stock in DaVita. Dr. Alambyan has stock in Invitae. Dr. Alambyan has stock in Pfizer. Dr. Alambyan has stock in Bristol-Myers Squibb. Dr. Alambyan has stock in Johnson and Johnson. Dr. Alambyan has stock in Merck. Dr. Alambyan has stock in Medtronic. Dr. Alambyan has stock in AbbVie. The institution of Dr. Alambyan has received research support from Albert Einstein Healthcare Network.
-
Dr. Mehdi has nothing to disclose.
-
Dr. Gezalian has nothing to disclose.
-
Dr. Ayodele has nothing to disclose.
-
Dr. Toossi has nothing to disclose.